ProShares UltraShort Profile

USD 0.56  3.12%

ProShares UltraShort Summary

ProShares UltraShort Nasdaq Biotech [BIS] is traded in USA and was established 2010-04-06. The fund is classified under Trading--Inverse Equity category within ProShares family. ProShares UltraShort Nasdaq Biotech currently have 27.88 M in assets under management (AUM). , while the total return for the last 3 years was -25.96%.
Check ProShares UltraShort Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

ProShares UltraShort Target Price Odds Analysis

Odds Below 18.5HorizonTargetOdds Above 18.5
88.31%30 days 18.50 11.59%
Based on normal probability distribution, the odds of ProShares UltraShort to move above current price in 30 days from now is about 11.59% (This ProShares UltraShort Nasdaq Biotech probability density function shows the probability of ProShares UltraShort Etf to fall within a particular range of prices over 30 days) .

ProShares UltraShort Risk Profiles

ProShares UltraShort Technical Analysis

The output start index for this execution was zero with a total number of output elements of seventeen. ProShares UltraShort Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe ProShares UltraShort price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

ProShares UltraShort Key Fundamentals

ProShares UltraShort Against Markets

ProShares UltraShort Current Ratings

ProShares UltraShort Nasdaq Biotech 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for ProShares UltraShort Nasdaq Biotech are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks daily investment results that correspond to two times the inverse of the daily performance of the Nasdaq Biotechnology Index. ProShares UltraShort is traded on NASDAQ General Markets in USA. more
NameProShares UltraShort Nasdaq Biotech
CEOMukhtar KalyanView All
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerProShares
ExchangeNASDAQ General Markets
Etf FamilyProShares
Fund CategorySector
Portfolio ConcentrationHealth Care
Phone866 776 5125
CurrencyUSD - US Dollar
DescriptionProShares UltraShort Nasdaq Biotechnology
Inception Date2010-04-07
BenchmarkNASDAQ Biotechnology TR USD
Entity TypeRegulated Investment Company
Asset Under Management27.54 Million
Average Trading Valume64,053
Asset TypeEquity
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorJ.P. Morgan Investor Services Co.
AdvisorProShare Advisors LLC
CustodianJPMorgan Chase Bank, N.A.
DistributorSEI Investments Distribution Co.
Portfolio ManagerMichael Neches, Tarak Dave
Transfer AgentJPMorgan Chase Bank, N.A.
Fiscal Year EndMay 31
ExchangeThe NASDAQ Stock Market LLC
Market MakerVirtu Financial
Total Expense1.11
Management Fee0.75
Nav Price15.62
Last Bear Mkt0.00%
Two Hundred Day Average18.84
Average Daily Volume In Three Month27.17k
Fifty Two Week Low15.38
Last Bull Mkt0.00%
Average Daily Volume Last 10 Day51.72k
Fifty Two Week High24.92
One Month0.31%
Fifty Day Average16.42
Three Month-19.63%
Check also Trending Equities. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.